Metropolis Healthcare, India’s second largest and most respected pathology laboratory chain, announced that it has been ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...

Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today that it has welcomed Dr. Josh ...

It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.

That observation was prompted by a visit to the walk-in storage cooler inside the Blood Bank in UAB Hospital. If you are squeamish at the sight of blood, this is not the place for you. When the door ...

HOUSTON, DECEMBER 4, 2025 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

Global Market OverviewThe Global Tissue Diagnostics Market is projected to grow at a CAGR of 7% by 2026. The market expansion is driven by the increasing prevalence of cancer and neoplastic diseases, ...

Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

A new article reflects on how two generations of scientists reshaped thinking on aging, linking hormonal regulation in the brain to molecular growth pathways. Mikhail Blagosklonny spent his career ...

Highlights need to integrate Artificial Intelligence (AI) and big data analysis into diagnostic processes for accuracy and ...